Esperion Therapeutics
ESPR
$1.90
Share price
-4.52%
Change (1 day)
43.94%
Change (1 year)
Categories
Esperion Therapeutics (ESPR) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.66 B
According to Esperion Therapeutics's latest financial reports the company's total liabilities are $0.66 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Esperion Therapeutics - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.66 B | 15.58% |
| 2022-12-31 | $0.57 B | -1.18% |
| 2021-12-31 | $0.57 B | 28.74% |
| 2020-12-31 | $0.44 B | 131.05% |
| 2019-12-31 | $0.19 B | 202.33% |
| 2018-12-31 | $64.33 M | 94.1% |
| 2017-12-31 | $33.14 M | 99.53% |
| 2016-12-31 | $16.61 M | 99.82% |
| 2015-12-31 | $8.31 M | -14.49% |
| 2014-12-31 | $9.72 M | 131.31% |
| 2013-12-31 | $4.2 M | -82.99% |
| 2012-12-31 | $24.7 M | 199.91% |
| 2011-12-31 | $8.23 M | |
| 2002-12-31 | $12.66 M | 6.94% |
| 2001-12-31 | $11.84 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $137.21 B | 20,664.99% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | $7.10 B | 975.55% | 🇺🇸 USA |
 Ultragenyx RARE | $1.21 B | 83.96% | 🇺🇸 USA |
 Lexicon Pharmaceuticals
LXRX | $0.13 B | -79.27% | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | $0.61 B | -6.52% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $1.89 B | 186.03% | 🇺🇸 USA |